Efficacy of Sodium‐Glucose Cotransporter‐2 Inhibitors in Patients With Acute Myocardial Infarction: A Meta‐Analysis of Randomised Controlled Trials
ABSTRACT Background Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular (CV) outcomes in patients with or without Type 2 diabetes and heart failure (HF). However, studies have shown conflicting evidence regarding their efficacy in patients following acute myocardial infarction (...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2024-09-01
|
| Col·lecció: | Endocrinology, Diabetes & Metabolism |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/edm2.514 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|